八味通达方辅助治疗变异型心绞痛患者的临床效果

doi:10.3969/j.issn.1671-7171.2026.03.009

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (1220 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the clinical effect of Bawei Tongda Decoction in adjuvant treatment of patients with variant angina pectoris. 【Methods】 A total of 80 patients with variant angina pectoris admitted to the Wuxi Mingci Cardiovascular Hospital from December 2023 to October 2024 were selected and divided into an observation group and a control group according to different treatment methods, with 40 cases in each group. The control group was given conventional western medicine treatment, and the observation group was additionally treated with Bawei Tongda Decoction on the basis of the control group. Both groups were treated continuously for 4 weeks. The clinical efficacy, TCM syndrome scores, Seattle Angina Questionnaire scores, frequency and duration of angina pectoris attacks, as well as serum levels of malondialdehyde (MDA), nitric oxide (NO) and superoxide dismutase (SOD) were compared between the two groups. 【Results】 After treatment, the frequency and duration of angina pectoris attacks in both groups were lower than those before treatment, and the observation group was lower than the control group, with statistically significant differences (P<0.05); the scores of chest pain, chest tightness, fatigue, palpitations and shortness of breath, and dark complexion in both groups were lower than those before treatment, and the observation group was lower than the control group, with statistically significant differences (P<0.05); the serum MDA level in both groups was lower than that before treatment, and the levels of NO and SOD were higher than those before treatment; in addition, the serum MDA level in the observation group was lower than that in the control group, and the levels of NO and SOD were higher than those in the control group (P<0.05); the scores of physical activity limitation, angina stability, angina attack, treatment satisfaction and disease cognition in both groups were higher than those before treatment, and the observation group was higher than the control group (P<0.05). The total effective rate of the observation group was higher than that of the control group, with a statistically significant difference (P<0.05). 【Conclusion】 Bawei Tongda Decoction has a good clinical effect in adjuvant treatment of patients with variant angina pectoris, which can effectively relieve angina pectoris symptoms, improve vascular function and enhance the quality of life of patients.

Key words： Angina Pectoris, Variant Phytotherapy Treatment Outcome

Received: 18 April 2025

PACS:

R541.42

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Bin
	WANG Chen
	ZHANG Kangkang

Cite this article:

WANG Bin,WANG Chen,ZHANG Kangkang. Clinical Effect of Bawei Tongda Decoction in Adjuvant Treatment of Patients with Variant Angina Pectoris[J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(3): 383-386.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2026.03.009 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2026/V43/I3/383

[1] 刘丹丹,夏思良. 冠状动脉痉挛性心绞痛腔内影像学特征与进展[J].中国临床研究,2021,34(4):558-560.
[2] MIZUTANI Y, ISHIKAWA T, NAKAHARA S, et al. Calcium channel blockers with and without nitrates for the prognosis of patients with coronary vasospastic angina: a Meta-analysis[J].Vascular Failure,2021, 5(1): 13-22.
[3] 王嘉恒,王丽颖,王凤,等. 从“扶正祛邪”辨治不稳定型心绞痛探析[J].中国中医急症,2024,33(1):66-70.
[4] 中华中医药学会. 中医内科常见病诊疗指南·中医病症部分[M]. 北京:中国中医药出版社,2008:39-42.
[5] 向定成,曾定尹,霍勇. 冠状动脉痉挛综合征诊断与治疗中国专家共识[J].中国介入心脏病学杂志,2015,23(4):181-186.
[6] 田琼. 医联体模式下健康管理干预对稳定型心绞痛伴高血压患者西雅图心绞痛量表评分及健康行为能力的影响[J].黑龙江医学,2022,46(3):323-325.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京中医药大学出版社,2002:97.
[8] NGUYEN T H, ONG G J, GIROLAMO O C, et al. Angina due to coronary artery spasm (variant angina): Diagnosis and intervention strategies[J].Expert Rev Cardiovasc Ther,2021, 19(10): 917-927.
[9] 舒鹏钦,陈铁龙,刘昭. 通冠益心方治疗冠状动脉痉挛性心绞痛患者的临床效果观察[J].中国医药,2025,20(1):100-104.
[10] 董新苗.加味瓜蒌薤白半夏汤联合麝香保心丸治疗老年稳定型心绞痛患者的临床效果[J].中国民康医学,2019,31(9):92-94.
[11] 何一婷, 智瑜. 宽胸祛痹汤辅助治疗对经皮冠状动脉介入术后心绞痛血管内皮功能及血清ADAMTS-13、血浆Irisin水平的影响[J].中华中医药学刊,2024,42(5):69-73.
[12] MATTA A, BOUISSET F, LHERMUSIER T, et al. Coronary artery spasm: new insights[J].J Interv Cardiol,2020, 2020(1): 5894586.
[13] CORDIANO R, DI GIOACCHINO M, MANGIFESTA R, et al. Malondialdehyde as a potential oxidative stress marker for allergy-oriented diseases: an update[J].Molecules,2023, 28(16): 5979.
[14] 武雪萍, 范红, 刘超峰, 等. 加味瓜蒌薤白半夏汤治疗冠心病痰瘀毒互结证的临床观察[J].世界中西医结合杂志, 2012, 7(9): 800-801.
[15] 赖长沙. 加味瓜蒌薤白半夏汤治疗老年稳定型心绞痛临床效果观察[J].中外医学研究, 2017, 15(8):3-4.